GALT Competitors & Alternatives
Compare Galectin Therapeutics Inc with similar stocks in the same industry
Biotechnology
GALT
Main Stock$3.84
Tradestie Score
41
Market Cap
$267.77M
Analyst Upside
+186.5%
Top Competitors
235 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ATXS
Astria Therapeutics, Inc. Common Stock
|
$12.58
|
$425.52M | - | 54 | Compare |
|
ALMS
Alumis Inc. Common Stock
|
$9.22
|
$422.50M | - | 49 | Compare |
|
DRUG
Bright Minds Biosciences Inc. Common Stock
|
$63.38
|
$410.79M | - | 54 | Compare |
|
FDMT
4D Molecular Therapeutics, Inc. Common Stock
|
$13.76
|
$407.71M | - | 43 | Compare |
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$13.52
|
$386.68M | - | 52 | Compare |
|
AURA
Aura Biosciences, Inc. Common Stock
|
$7.01
|
$382.04M | - | 44 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$14.40
|
$371.64M | - | 49 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$20.40
|
$354.45M | - | 41 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$44.84
|
$353.70M | - | 43 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.81
|
$350.98M | - | 48 | Compare |
More GALT Analysis
Data updated: Sep 15, 2026 | Industry: Biotechnology (SIC 2834)
235 stocks in this industry